Rentokil Initial (ADR)
Runs route-based pest-control and hygiene networks centred on North America.
Something off on this page? Send us feedback.
Profile
Provides pest-control and hygiene services through route-based networks, with Pest Control as the dominant activity. The Terminix combination made North America the largest operating centre, while recurring bolt-on acquisitions expand route density and the multi-year integration remains a core execution dependency.
Provides pest-control and Hygiene & Wellbeing services through route-based networks across North America and international markets. Pest Control is the dominant activity, covering rodents, insects, timber treatment and connected monitoring, while Hygiene & Wellbeing is the smaller reportable activity.
Builds service density by combining local field operations with bolt-on acquisitions. The Terminix combination made North America the group’s largest operating centre and added substantial US residential and termite exposure alongside the existing international network.
Execution depends on completing a multi-year integration across branches, systems, brands and operating practices without disrupting customers. The acquisition model also depends on absorbing local businesses while preserving customer relationships and route density.
Company facts
Key statistics
Year to date −21.2% · Average volume (30d) 1.6M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Target |
|---|---|---|---|---|---|
| Jul 31, 2026 | BNP Paribas | Target | $26.70 | ||
| Jul 31, 2026 | Exane BNP Paribas | Downgrade | Neutral | ||
| Jul 7, 2026 | Goldman Sachs | Upgrade | Neutral | Buy | |
| Jul 6, 2026 | Goldman Sachs | Upgrade | Buy | ||
| Mar 12, 2026 | UBS | Upgrade | Neutral | Buy |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $0.66 | $0.39 | −41.3% | $3.53B | $3.59B | +1.6% | −3.67% |
| Mar 5, 2026Q4 FY25 | $0.70 | $0.65 | −7.1% | $3.55B | $3.54B | −0.3% | −0.41% |
| Jul 31, 2025Q2 FY25 | $0.65 | $0.51 | −22.5% | $3.55B | $4.58B | +29.0% | −4.24% |
| Mar 6, 2025Q4 FY24 | $0.63 | $0.27 | −56.4% | $3.50B | $3.42B | −2.4% | +1.32% |
Financial highlights
| 12 quarters | Q4 FY23 | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $2.70B | $2.71B | $2.73B | $4.58B | $3.53B | $3.61B | |
| Gross profit | $4.09B | $385.0M | $341.0M | $620.0M | $489.5M | $505.9M | |
| Operating income | $262.0M | $321.0M | $228.0M | $414.3M | $489.5M | $351.0M | |
| Net income | $196.0M | $196.0M | $111.0M | $256.2M | $280.6M | $197.1M | |
| Diluted EPS | $0.39 | $0.39 | $0.22 | $0.44 | $0.55 | $0.39 | |
| Gross margin | 151.1% | 14.2% | 12.5% | 13.5% | 13.9% | 14.0% | |
| Operating margin | 9.7% | 11.9% | 8.4% | 9.0% | 13.9% | 9.7% |
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $2.49B · Total debt $6.18B · Total assets $14.64B · Shareholders' equity $5.55B
Dividends
Raised for 3 straight years. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 14, 2026 | Aug 14 | Sep 21 | $0.224 | cut from $0.412 |
| Apr 10, 2026 | Apr 10 | May 19 | $0.412 | raised from $0.2075 |
| Aug 15, 2025 | Aug 15 | Sep 23 | $0.2075 | cut from $0.3942 |
| Apr 4, 2025 | Apr 4 | May 15 | $0.3942 | raised from $0.2072 |
| Aug 9, 2024 | Aug 9 | Sep 17 | $0.2072 | cut from $0.3747 |
| Apr 4, 2024 | Apr 5 | May 16 | $0.3747 | raised from $0.1548 |
| Aug 3, 2023 | Aug 4 | Sep 12 | $0.1548 | cut from $0.2823 |
| Apr 10, 2023 | Apr 11 | May 18 | $0.2823 | raised from $0.146 |
Ownership
Shares outstanding 503.25M · Float 495.89M · 98.5% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 175.10M | 6.90% | 13G | Apr 30, 2026 |
| GIC Private Ltd | 159.67M | 6.32% | 13G | May 9, 2025 |
| Janus Henderson Group PLC | 142.44M | 5.60% | 13G | Nov 14, 2025 |
| Ein # | 135.52M | 5.40% | 13D/G | Nov 14, 2024 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Rollins
Largest listed pure-play rival across residential and commercial pest control
- Ecolab
Commercial pest and hygiene overlap across foodservice and regulated facilities
- Cintas
Route-based rival in restroom services, supplies, mats, and workplace hygiene
- Kimberly-Clark
Branded washroom consumables and dispensers competing with Initial Hygiene
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Rentokil Initial (ADR) | $23.53 | +0.02% | $11.84B | 50.1 | — | 1.4 | −21.7% |
| Rollins | $36.24 | −0.38% | $17.50B | 33.1 | 30.4 | 4.5 | +7.9% |
| Ecolab | $275.05 | −4.11% | $80.70B | 38.5 | 33.2 | 4.8 | +9.7% |
| Cintas | $198.36 | −2.86% | $81.71B | 41.6 | 37.1 | 7.3 | +8.9% |
| Kimberly-Clark | $110.00 | +0.42% | $36.36B | 18.6 | 15.5 | 2.2 | +0.6% |
| Median | 35.8 | 31.8 | 4.6 | +8.4% |